Income Statement Neuronetics, Inc.

Equities

STIM

US64131A1051

Advanced Medical Equipment & Technology

Market Closed - Nasdaq Other stock markets 04:00:00 2025-01-23 pm EST			5-day change	1st Jan Change
2.390 ^USD	+1.70%		+4.82%	+48.45%

Jan. 13	Neuronetics, Inc. Announces Unaudited Revenue Results for Fourth Quarter and Full Year 2024	CI
Jan. 13	Neuronetics, Inc. Provides Earnings Guidance for the Full Year 2025	CI

5d191e4dfffa464d14bd0.dKb_nh8s5kFhLb4ZPK9JWk4cufr8fkVLQU5m24uP6t4.QMSp9m1Hki4iVMxID_4fOyF2ipe2Nz8CJCclrrntuJJCysjxeRWXLyUahg

Published financial data: NEURONETICS, INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2019	2020	2021	2022	2023
Revenues	62.66M	49.24M	55.31M	65.21M	71.35M
Total Revenues	62.66M	49.24M	55.31M	65.21M	71.35M
Cost of Goods Sold, Total	15.39M	11.55M	11.65M	15.48M	17.74M
Gross Profit	47.27M	37.69M	43.66M	49.72M	53.6M
Selling General & Admin Expenses, Total	60.45M	49M	62.8M	74.9M	72.64M
R&D Expenses	13.75M	9.2M	7.92M	9.34M	9.52M
Other Operating Expenses, Total	74.2M	58.2M	70.72M	84.23M	82.16M
Operating Income	-26.93M	-20.51M	-27.06M	-34.51M	-28.55M
Interest Expense, Total	-3.68M	-4.52M	-4.02M	-4.25M	-5.42M
Interest And Investment Income	-	302K	390K	2.2M	600K
Net Interest Expenses	-3.68M	-4.22M	-3.63M	-2.05M	-4.82M
Other Non Operating Income (Expenses)	1.57M	-	-	-	2.29M
EBT, Excl. Unusual Items	-29.04M	-24.73M	-30.69M	-36.56M	-31.09M
Asset Writedown	-	-	-	-	-2M
Other Unusual Items	-	-2.72M	-500K	-600K	2.9M
EBT, Incl. Unusual Items	-29.04M	-27.45M	-31.19M	-37.16M	-30.19M
Earnings From Continuing Operations	-29.04M	-27.45M	-31.19M	-37.16M	-30.19M
Net Income to Company	-29.04M	-27.45M	-31.19M	-37.16M	-30.19M
Net Income - (IS)	-29.04M	-27.45M	-31.19M	-37.16M	-30.19M
Net Income to Common Incl Extra Items	-29.04M	-27.45M	-31.19M	-37.16M	-30.19M
Net Income to Common Excl. Extra Items	-29.04M	-27.45M	-31.19M	-37.16M	-30.19M
Per Share Items
Net EPS - Basic	-1.58	-1.46	-1.22	-1.38	-1.05
Basic EPS - Continuing Operations	-1.58	-1.46	-1.22	-1.38	-1.05
Basic Weighted Average Shares Outstanding	18.38M	18.84M	25.48M	26.9M	28.66M
Net EPS - Diluted	-1.58	-1.46	-1.22	-1.38	-1.05
Diluted EPS - Continuing Operations	-1.58	-1.46	-1.22	-1.38	-1.05
Diluted Weighted Average Shares Outstanding	18.38M	18.84M	25.48M	26.9M	28.66M
Normalized Basic EPS	-0.99	-0.82	-0.75	-0.85	-0.68
Normalized Diluted EPS	-0.99	-0.82	-0.75	-0.85	-0.68
Supplemental Items
EBITDA	-25.86M	-19.57M	-26M	-32.86M	-26.64M
EBITA	-26.93M	-20.51M	-27.06M	-34.51M	-28.55M
EBIT	-26.93M	-20.51M	-27.06M	-34.51M	-28.55M
EBITDAR	-25.36M	-18.97M	-25.3M	-32.06M	-25.84M
Normalized Net Income	-18.15M	-15.46M	-19.18M	-22.85M	-19.43M
Interest on Long-Term Debt	3.68M	4.52M	4.02M	4.25M	5.42M
Supplemental Operating Expense Items
Selling and Marketing Expenses	42.99M	32.56M	37.75M	49.98M	47.22M
General and Administrative Expenses	17.46M	16.44M	25.05M	24.92M	25.43M
Research And Development Expense From Footnotes	13.75M	9.2M	7.92M	9.34M	9.52M
Net Rental Expense, Total	500K	600K	700K	800K	800K
Imputed Operating Lease Interest Expense	455K	597K	578K	686K	679K
Imputed Operating Lease Depreciation	44.51K	2.55K	122K	114K	121K
Stock-Based Comp., COGS (Total)	67K	66K	79K	130K	140K
Stock-Based Comp., R&D Exp. (Total)	432K	449K	198K	462K	677K
Stock-Based Comp., S&M Exp. (Total)	1.34M	1.81M	2.1M	4.29M	2.33M
Stock-Based Comp., G&A Exp. (Total)	1.6M	2.08M	5.5M	3.87M	4.17M
Total Stock-Based Compensation	3.43M	4.4M	7.87M	8.75M	7.32M

Fiscal Period: December	2019	2020	2021	2022	2023
Assets
Cash And Equivalents	75.71M	48.96M	94.14M	70.34M	59.68M
Total Cash And Short Term Investments	75.71M	48.96M	94.14M	70.34M	59.68M
Accounts Receivable, Total	7.45M	9.05M	9.9M	15.13M	16.69M
Other Receivables	-	-	-	-	2.9M
Notes Receivable	-	-	74K	230K	2.06M
Total Receivables	7.45M	9.05M	9.98M	15.36M	21.64M
Inventory	2.78M	3.72M	6.56M	8.9M	8.09M
Prepaid Expenses	1.83M	2.19M	3.09M	2.17M	1.87M
Other Current Assets, Total	689K	1.1M	1.56M	2M	2.51M
Total Current Assets	88.45M	65.01M	115M	98.77M	93.79M
Gross Property Plant And Equipment	7.11M	6.55M	7.64M	8.38M	7.6M
Accumulated Depreciation	-2.21M	-2.4M	-2.54M	-3.06M	-2.82M
Net Property Plant And Equipment	4.9M	4.15M	5.1M	5.32M	4.78M
Other Intangibles, Total	1.2M	1.2M	-	3.6M	4.2M
Accounts Receivable Long-Term	1.73M	2.33M	1.7M	1.22M	661K
Loans Receivable Long-Term	-	-	10.11M	362K	3.8M
Deferred Charges Long-Term	3.78M	5.3M	6.76M	7.57M	8.37M
Other Long-Term Assets, Total	105K	666K	2.22M	45K	230K
Total Assets	100M	78.66M	141M	117M	116M
Liabilities
Accounts Payable, Total	4.62M	3.75M	4.3M	2.43M	4.75M
Accrued Expenses, Total	8.39M	6.78M	7.93M	14.51M	12.38M
Current Portion of Long-Term Debt	11.25M	-	-	13.12M	-
Current Portion of Leases	559K	594K	670K	824K	845K
Unearned Revenue Current, Total	2.23M	2.02M	2.5M	1.98M	1.62M
Other Current Liabilities	639K	536K	306K	328K	213K
Total Current Liabilities	27.69M	13.68M	15.7M	33.2M	19.81M
Long-Term Debt	19.9M	34.62M	35.34M	22.83M	59.28M
Long-Term Leases	2.62M	3.12M	3.54M	2.97M	2.35M
Unearned Revenue Non Current	2.11M	1.74M	1.47M	829K	200K
Other Non Current Liabilities	-	-	-	-	-
Total Liabilities	52.32M	53.16M	56.05M	59.82M	81.64M
Preferred Stock Convertible	-	-	-	-	-
Preferred Stock - Others	-	-	-	-	-
Total Preferred Equity	-	-	-	-	-
Common Stock, Total	186K	191K	264K	273K	291K
Additional Paid In Capital	298M	303M	394M	403M	410M
Retained Earnings	-250M	-278M	-309M	-346M	-376M
Total Common Equity	47.85M	25.49M	85.18M	57.06M	34.19M
Total Equity	47.85M	25.49M	85.18M	57.06M	34.19M
Total Liabilities And Equity	100M	78.66M	141M	117M	116M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	18.67M	25.41M	26.63M	28.36M	29.76M
ECS Total Common Shares Outstanding	18.64M	19.11M	26.4M	27.27M	29.09M
Book Value / Share	2.57	1.33	3.23	2.09	1.18
Tangible Book Value	46.65M	24.29M	85.18M	53.46M	29.99M
Tangible Book Value Per Share	2.5	1.27	3.23	1.96	1.03
Total Debt	34.33M	38.34M	39.54M	39.74M	62.47M
Net Debt	-41.38M	-10.62M	-54.6M	-30.6M	2.8M
Debt Equivalent Oper. Leases	4M	4.8M	5.6M	6.4M	6.4M
Account Code - Inventory Valuation	5	5	5	5	5
Machinery, Total	2.89M	2.68M	3.29M	3.61M	2.85M
Full Time Employees	235	126	175	194	203
Assets on Operating Lease - Gross	-	-	-	-	542K
Assets on Operating Lease - Accumulated Depreciation	-	-	-	-	-42K
Accumulated Allowance for Doubtful Accounts (Supple)	548K	1.01M	1.46M	1.65M	795K

Fiscal Period: December	2019	2020	2021	2022	2023
Net Income	-29.04M	-27.45M	-31.19M	-37.16M	-30.19M
Depreciation & Amortization - CF	1.06M	941K	1.06M	1.65M	2.01M
Depreciation & Amortization, Total	1.06M	941K	1.06M	1.65M	2.01M
Stock-Based Compensation (CF)	3.43M	4.4M	7.87M	8.75M	7.32M
Provision and Write-off of Bad Debts	-	-	-	-	390K
Other Operating Activities, Total	976K	1.99M	918K	801K	2.54M
Change In Accounts Receivable	-950K	-597K	-3.05M	-6.32M	-8.83M
Change In Inventories	-306K	-945K	-3.44M	-2.59M	-1.1M
Change In Accounts Payable	299K	-1.08M	276K	-1.97M	2.03M
Change in Unearned Revenues	138K	-573K	215K	-1.16M	-989K
Change in Other Net Operating Assets	-6.09M	-5.08M	-630K	7.26M	-5.21M
Cash from Operations	-30.48M	-28.39M	-27.98M	-30.74M	-32.04M
Capital Expenditure	-813K	-730K	-2.35M	-3.27M	-2.37M
Other Investing Activities, Total	-	-	-7.49M	10M	1.05M
Cash from Investing	-813K	-730K	-9.84M	6.73M	-1.32M
Long-Term Debt Issued, Total	-	41.36M	-	-	25M
Total Debt Issued	-	41.36M	-	-	25M
Long-Term Debt Repaid, Total	-	-38.86M	-	-	-1.2M
Total Debt Repaid	-	-38.86M	-	-	-1.2M
Issuance of Common Stock	2.42M	690K	83.41M	298K	1K
Issuance of Preferred Stock	-	-	-	-	-
Other Financing Activities, Total	-	-821K	-401K	-91K	-1.1M
Cash from Financing	2.42M	2.37M	83.01M	207K	22.7M
Net Change in Cash	-28.88M	-26.75M	45.18M	-23.8M	-10.66M
Supplemental Items
Cash Interest Paid	2.95M	3.89M	3.3M	3.54M	4.79M
Levered Free Cash Flow	-15.98M	-17.14M	-16.04M	-20.12M	-20.25M
Unlevered Free Cash Flow	-13.67M	-14.31M	-13.53M	-17.47M	-16.86M
Change In Net Working Capital	528K	6.11M	3.19M	3.02M	5.97M
Net Debt Issued / Repaid	-	2.5M	-	-	23.8M

Fiscal Period: December	2019	2020	2021	2022	2023
Profitability
Return on Assets	-15.5	-14.34	-15.39	-16.71	-15.34
Return on Total Capital	-18.33	-17.56	-17.94	-19.47	-18.45
Return On Equity %	-48.86	-74.86	-56.37	-52.25	-66.17
Return on Common Equity	-48.86	-74.86	-56.37	-52.25	-66.17
Margin Analysis
Gross Profit Margin %	75.44	76.54	78.93	76.26	75.13
SG&A Margin	96.48	99.5	113.54	114.86	101.82
EBITDA Margin %	-41.28	-39.74	-47.01	-50.4	-37.34
EBITA Margin %	-42.98	-41.65	-48.93	-52.93	-40.02
EBIT Margin %	-42.98	-41.65	-48.93	-52.93	-40.02
Income From Continuing Operations Margin %	-46.35	-55.75	-56.39	-56.99	-42.31
Net Income Margin %	-46.35	-55.75	-56.39	-56.99	-42.31
Net Avail. For Common Margin %	-46.35	-55.75	-56.39	-56.99	-42.31
Normalized Net Income Margin	-28.97	-31.39	-34.68	-35.04	-27.23
Levered Free Cash Flow Margin	-25.5	-34.8	-29	-30.86	-28.38
Unlevered Free Cash Flow Margin	-21.82	-29.06	-24.46	-26.79	-23.63
Asset Turnover
Asset Turnover	0.58	0.55	0.5	0.51	0.61
Fixed Assets Turnover	19.95	10.88	11.96	12.51	14.13
Receivables Turnover (Average Receivables)	9.59	5.97	5.84	5.21	4.49
Inventory Turnover (Average Inventory)	5.91	3.56	2.27	2	2.09
Short Term Liquidity
Current Ratio	3.19	4.75	7.34	2.98	4.73
Quick Ratio	3	4.24	6.63	2.57	4
Operating Cash Flow to Current Liabilities	-1.1	-2.07	-1.78	-0.93	-1.62
Days Sales Outstanding (Average Receivables)	38.07	61.32	62.55	70.06	81.38
Days Outstanding Inventory (Average Inventory)	61.75	102.87	161.04	182.25	174.78
Average Days Payable Outstanding	97.22	122.6	101.32	68.95	77.42
Cash Conversion Cycle (Average Days)	2.59	41.59	122.27	183.37	178.74
Long Term Solvency
Total Debt/Equity	71.73	150.37	46.43	69.65	182.73
Total Debt / Total Capital	41.77	60.06	31.71	41.06	64.63
LT Debt/Equity	47.06	148.04	45.64	45.21	180.25
Long-Term Debt / Total Capital	27.4	59.13	31.17	26.65	63.76
Total Liabilities / Total Assets	52.23	67.59	39.69	51.18	70.48
EBIT / Interest Expense	-7.31	-4.54	-6.73	-8.12	-5.26
EBITDA / Interest Expense	-6.88	-4.19	-6.3	-7.54	-4.76
(EBITDA - Capex) / Interest Expense	-7.1	-4.36	-6.88	-8.31	-5.2
Total Debt / EBITDA	-1.35	-2.02	-1.56	-1.24	-2.42
Net Debt / EBITDA	1.63	0.56	2.16	0.95	-0.11
Total Debt / (EBITDA - Capex)	-1.31	-1.95	-1.43	-1.12	-2.21
Net Debt / (EBITDA - Capex)	1.58	0.54	1.97	0.87	-0.1
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	18.72	-21.41	12.32	17.89	9.42
Gross Profit, 1 Yr. Growth %	17.2	-20.26	15.84	13.89	7.81
EBITDA, 1 Yr. Growth %	36.48	-24.35	32.89	26.38	-20.63
EBITA, 1 Yr. Growth %	35.78	-23.84	31.96	27.52	-18.68
EBIT, 1 Yr. Growth %	35.78	-23.84	31.96	27.52	-18.68
Earnings From Cont. Operations, 1 Yr. Growth %	20.53	-5.48	13.62	19.13	-18.76
Net Income, 1 Yr. Growth %	20.53	-5.48	13.62	19.13	-18.76
Normalized Net Income, 1 Yr. Growth %	21.03	-14.86	24.12	19.11	-16.34
Diluted EPS Before Extra, 1 Yr. Growth %	-41.32	-7.76	-16.01	12.83	-23.74
Accounts Receivable, 1 Yr. Growth %	32.54	21.53	9.4	52.76	10.3
Inventory, 1 Yr. Growth %	14.1	34.05	76.42	35.59	-9.06
Net Property, Plant and Equip., 1 Yr. Growth %	255.81	-15.4	23.05	4.19	-10.08
Total Assets, 1 Yr. Growth %	-14.4	-21.48	79.54	-17.23	-0.9
Tangible Book Value, 1 Yr. Growth %	-33.39	-47.93	250.62	-35.34	-43.9
Common Equity, 1 Yr. Growth %	-32.64	-46.73	234.11	-33.01	-40.08
Cash From Operations, 1 Yr. Growth %	48.04	-6.86	-1.43	9.85	4.23
Capital Expenditures, 1 Yr. Growth %	-19.58	-10.21	222.33	38.93	-27.53
Levered Free Cash Flow, 1 Yr. Growth %	17.87	7.27	-6.4	25.45	-1.21
Unlevered Free Cash Flow, 1 Yr. Growth %	21.55	4.67	-5.47	29.1	-5.5
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	24.48	-3.4	-6.04	15.07	13.57
Gross Profit, 2 Yr. CAGR %	23.88	-3.33	-3.89	14.86	10.81
EBITDA, 2 Yr. CAGR %	40.99	1.61	0.27	24.01	0.16
EBITA, 2 Yr. CAGR %	40.68	1.69	0.25	24.38	1.78
EBIT, 2 Yr. CAGR %	40.68	1.69	0.25	24.38	1.78
Earnings From Cont. Operations, 2 Yr. CAGR %	34.48	6.74	3.63	16.34	-1.62
Net Income, 2 Yr. CAGR %	34.48	6.74	3.63	16.34	-1.62
Normalized Net Income, 2 Yr. CAGR %	34.48	1.3	2.8	17.39	-0.17
Diluted EPS Before Extra, 2 Yr. CAGR %	-86.47	-26.43	-11.98	-2.65	-7.24
Accounts Receivable, 2 Yr. CAGR %	32.13	26.92	15.31	29.27	29.8
Inventory, 2 Yr. CAGR %	6.04	23.68	53.79	54.67	11.05
Net Property, Plant and Equip., 2 Yr. CAGR %	89.94	73.5	2.03	13.23	-3.21
Total Assets, 2 Yr. CAGR %	60.39	-18.01	18.74	21.9	-9.44
Tangible Book Value, 2 Yr. CAGR %	-50.84	-41.11	35.12	48.35	-39.77
Common Equity, 2 Yr. CAGR %	-50.16	-40.1	33.42	49.61	-36.64
Cash From Operations, 2 Yr. CAGR %	65.39	17.42	-4.19	4.05	7
Capital Expenditures, 2 Yr. CAGR %	16.99	-15.03	70.12	111.61	0.34
Levered Free Cash Flow, 2 Yr. CAGR %	36.35	12.44	0.2	4.97	11.28
Unlevered Free Cash Flow, 2 Yr. CAGR %	41.41	12.79	-0.53	6.37	10.37
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	22.33	6.79	1.58	1.34	13.16
Gross Profit, 3 Yr. CAGR %	19.63	6.96	2.68	1.7	12.46
EBITDA, 3 Yr. CAGR %	43.99	14.57	11.12	8.31	7.62
EBITA, 3 Yr. CAGR %	42.35	14.65	10.92	8.62	8.57
EBIT, 3 Yr. CAGR %	42.35	14.65	10.92	8.62	8.57
Earnings From Cont. Operations, 3 Yr. CAGR %